Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)

The National Institutes of Health is seeking research proposals to advance translational research on the emergence and trajectory of schizophrenia and related disorders in mid to late life. The purpose of this initiative is to identify targets for future development of prevention and treatment efforts. The research should focus on understanding the mechanisms underlying the generation and trajectory of the illness in this age group. • The research should be translational, focusing on the emergence and trajectory of schizophrenia and related disorders in mid to late life. • The research should aim to identify targets for future development of prevention and treatment efforts. • The research should be relevant to the NIH's mission and priorities. • The research should be conducted by eligible applicants, including public and state controlled institutions of higher education, private institutions of higher education, and other organizations.